GlassScriptPhysician profile
Jeffery M Rawlings
NPI 1861474132
$3,165.25
in general payments reported to CMS, 2019-2025
18 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $181 · 2021: $521 · 2022: $455 · 2023: $545 · 2024: $639 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,236.34 | 2019-2022 | |
| Abbvie INC. | $890.31 | 2023-2025 | |
| Mentor Worldwide LLC | $425.51 | 2019-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Ethicon US, LLC | $103.77 | 2022-2025 | Surgiflo Hemostatic Matrix, Ethicon, Stratafix |
| Revance Therapeutics, INC. | $89.34 | 2024 | Daxxify |
| Merz North America, INC. | $69.48 | 2023 | Xeomin |
| Organogenesis INC. | $61.06 | 2023 | Puraply |
| Kerecis Limited | $56.15 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Cgg Medical INC | $40.34 | 2025 | |
| Triad Life Sciences INC. | $29.17 | 2022 | |
| Endo Pharmaceuticals INC. | $27.98 | 2019 | |
| Mimedx Group, INC. | $25.06 | 2024 | |
| Integra Lifesciences Corporation | $22.80 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Eagle Pharmaceuticals, INC. | $21.43 | 2023 | |
| Galderma Laboratories, L.P. | $18.70 | 2024 | Dysport |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.82 | 2025 | Collagenase Santyl |
| Davol INC. | $16.71 | 2019 | |
| Kci USA, INC. | $14.28 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Rawlings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.